GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Net Income From Continuing Operations

Albert Labs International (XCNQ:ABRT) Net Income From Continuing Operations : C$-2.31 Mil (TTM As of Sep. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Albert Labs International's net income from continuing operations for the three months ended in Sep. 2023 was C$-0.02 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Sep. 2023 was C$-2.31 Mil.

Albert Labs International Net Income From Continuing Operations Historical Data

The historical data trend for Albert Labs International's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International Net Income From Continuing Operations Chart

Albert Labs International Annual Data
Trend Dec21 Dec22
Net Income From Continuing Operations
-1.88 -7.06

Albert Labs International Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.54 -1.75 -0.39 -0.16 -0.02

Albert Labs International Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.31 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Albert Labs International (XCNQ:ABRT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Net Income From Continuing Operations
Comparable Companies
XCNQ:MYND XCNQ:ENBI TSXV:IBO XCNQ:HAVN XCNQ:GTTX XCNQ:MOOD XCNQ:WESA.X TSXV:BTI XCNQ:AGN XCNQ:CURE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6
Website
https://www.albertlabs.com
Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (XCNQ:ABRT) Headlines

No Headlines